These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 8100551)
1. Immune-mediated mechanisms and immune activation of fibroblasts in the pathogenesis of eosinophilia-myalgia syndrome induced by L-tryptophan. Illa I; Dinsmore S; Dalakas MC Hum Pathol; 1993 Jul; 24(7):702-9. PubMed ID: 8100551 [TBL] [Abstract][Full Text] [Related]
2. Eosinophilia myalgia syndrome: I. Immunocytochemical evidence for a T-cell-mediated immune effector response. Emslie-Smith AM; Engel AG; Duffy J; Bowles CA Ann Neurol; 1991 May; 29(5):524-8. PubMed ID: 1859182 [TBL] [Abstract][Full Text] [Related]
3. Eosinophilia-myalgia syndrome: a clinicopathological study of four patients. Villanova M; De Clerck LS; Cras P; Ceuterick C; Van Marck E; Guazzi GC; Martin JJ Clin Neuropathol; 1993; 12(4):201-3. PubMed ID: 8403629 [TBL] [Abstract][Full Text] [Related]
4. Elevated expression in situ of selectin and immunoglobulin superfamily type adhesion molecules in retroocular connective tissues from patients with Graves' ophthalmopathy. Heufelder AE; Bahn RS Clin Exp Immunol; 1993 Mar; 91(3):381-9. PubMed ID: 7680294 [TBL] [Abstract][Full Text] [Related]
5. Persistent microvasculopathy in chronic eosinophilia-myalgia syndrome. Smith SA Adv Exp Med Biol; 1996; 398():359-64. PubMed ID: 8906289 [TBL] [Abstract][Full Text] [Related]
6. The cause and pathogenesis of the eosinophilia-myalgia syndrome. Varga J; Uitto J; Jimenez SA Ann Intern Med; 1992 Jan; 116(2):140-7. PubMed ID: 1727618 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the pathology of fascia in eosinophilic myalgia syndrome patients and idiopathic eosinophilic fasciitis. Umbert I; Winkelmann RK; Wegener L Dermatology; 1993; 186(1):18-22. PubMed ID: 8435512 [TBL] [Abstract][Full Text] [Related]
9. 1,1'-Ethylidenebis[tryptophan] induces pathologic alterations in muscle similar to those observed in the eosinophilia-myalgia syndrome. Emslie-Smith AM; Mayeno AN; Nakano S; Gleich GJ; Engel AG Neurology; 1994 Dec; 44(12):2390-2. PubMed ID: 7991132 [TBL] [Abstract][Full Text] [Related]
10. Eosinophilia myalgia syndrome: absence of immunoglobulin reactivity suggests a cellular rather than humoral mechanism. Villanova M; De Clerck LS; Cras P; Guazzi GC; Martin JJ Acta Neurol Belg; 1994; 94(3):200-4. PubMed ID: 7976226 [TBL] [Abstract][Full Text] [Related]
11. A comparative study on antibodies to nucleoli and 5-hydroxytryptamine in patients with fibromyalgia syndrome and tryptophan-induced eosinophilia-myalgia syndrome. Klein R; Berg PA Clin Investig; 1994 Jul; 72(7):541-9. PubMed ID: 7981584 [TBL] [Abstract][Full Text] [Related]
12. A murine model of the eosinophilia-myalgia syndrome induced by 1,1'-ethylidenebis (L-tryptophan). Silver RM; Ludwicka A; Hampton M; Ohba T; Bingel SA; Smith T; Harley RA; Maize J; Heyes MP J Clin Invest; 1994 Apr; 93(4):1473-80. PubMed ID: 8163652 [TBL] [Abstract][Full Text] [Related]
13. [A case of the eosinophilia-myalgia syndrome]. Ishikawa A; Akahosi T; Okada J; Kondo H; Kasiwazaki S Ryumachi; 1992 Aug; 32(4):327-30; discussion 330-2. PubMed ID: 1411794 [TBL] [Abstract][Full Text] [Related]
14. Expression of class II-MHC antigens in the dermis of patients with progressive systemic sclerosis. Gruschwitz M; Sepp N; Kofler H; Wick G Immunobiology; 1991 Jun; 182(3-4):234-55. PubMed ID: 1833311 [TBL] [Abstract][Full Text] [Related]
15. Increased type I collagen gene expression in L-tryptophan associated eosinophilia-myalgia syndrome skin fibroblasts. Varga J; Li L; Jimenez SA J Rheumatol; 1993 Aug; 20(8):1303-8. PubMed ID: 8230009 [TBL] [Abstract][Full Text] [Related]